| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +10 K | 9.5% | $1.78 | +$17.8 K |
| Sells | 2 | -95 K | 90.5% | $2.02 | -$192 K |
| Net | -1 | -85 K | -81% | -$174 K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Cuong V. Do | President & CEO, Director | $737 K | +$17.8 K | +2.48% | Mar 4, 2024 |
| Richard J. Berman | Director | $117 K | -$37.8 K | -24.4% | Nov 9, 2023 |
| James Paul Lang | Director | $116 K | Nov 9, 2023 | ||
| Jonathan Adams | EVP Liver Cirrhosis Programs | $82.2 K | Feb 2, 2022 | ||
| Penelope Markham | EVP Liver Cirrhosis R&D | $80.9 K | Feb 16, 2023 | ||
| Steve Gorlin | Director | $78.3 K | -$154 K | -66.3% | Nov 9, 2023 |
| Joanne Wendy Kim | Chief Financial Officer | $74.6 K | Dec 11, 2023 | ||
| Robert J. Hariri | Director | $71.4 K | Nov 9, 2023 | ||
| Sigmund Rogich | Director | $71.4 K | Nov 9, 2023 | ||
| Clarence Ahlem | EVP Neuroscience Product Dev. | $62.8 K | Feb 16, 2023 | ||
| Christopher Reading | EVP Neuroscience R&D | $62.8 K | Feb 16, 2023 | ||
| Joseph M. Palumbo | Chief Medical Officer | Jun 7, 2023 | |||
| Michael Sherman | Director | Nov 9, 2023 | |||
| Terren S. Peizer | Director, 10%+ Owner | Nov 23, 2022 |
| Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|